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Abstract
Some smokeless tobacco products, such as Swedish snus, are today considered to be associated with substantially
fewer health hazards than cigarettes. This risk differential has contributed to the scientific debate about the
possibilities of harm reduction within the tobacco area. Although current manufacturing methods for snus build on
those that were introduced more than a century ago, the low levels of unwanted substances in modern Swedish
snus are largely due to improvements in production techniques and selection of raw materials in combination
with several programs for quality assurance and quality control. These measures have been successively introduced
during the past 30-40 years. In the late 1990s they formed the basis for a voluntary quality standard for Swedish
snus named GothiaTek
®. In recent years the standard has been accepted by the members of the trade
organization European Smokeless Tobacco Council (ESTOC) so it has now evolved into an industrial standard for all
smokeless tobacco products in Europe.
The initial impetus for the mentioned changes of the production was quality problems related to microbial activity
and formation of ammonia and nitrite in the finished products. Other contributing factors were that snus came
under the jurisdiction of the Swedish Food Act in 1971, and concerns that emerged in the 1960s and 1970s about
health effects of tobacco, and the significance of agrochemical residues and other potential toxicants in food stuffs.
This paper summarizes the historical development of the manufacture of Swedish snus, describes the chemical
composition of modern snus, and gives the background and rationale for the GothiaTek
® standard, including the
selection of constituents for which the standard sets limits. The paper also discusses the potential future of this
voluntary standard in relation to current discussions about tobacco harm reduction and regulatory science in
tobacco control.
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Introduction
The term smokeless tobacco (ST) includes a broad
range of products that vary considerably with regard to
composition and content of potential toxicants [1,2].
Consequently, there is also a large variability with regard
to health effects (this concept is sometimes referred to
as “continuum of risk”). The Royal College of Physicians
in London stated that “smokeless tobacco is 10-1,000 less
hazardous to health than smoking, depending on the
product” [3]. In line with this statement, the WHO
Tobacco Regulatory Committee (TobReg) recently con-
cluded that “Among the smokeless tobacco products on
the market, products with low levels of nitrosamines,
such as Swedish snus, are considerably less hazardous
than cigarettes...” [2].
The health effect profile of Swedish snus and the abil-
ity of snus to replace cigarettes among smokers has
been evidenced by numerous epidemiological studies
[4-6]. Cultural factors have probably contributed to the
observed usage patterns. However, the most important
determinants of health effects among individual users
are the chemical properties of the product. The manu-
facture of Swedish snus has in principle remained the
same since the early 1800s. However, as snus became
more popular in Sweden during the late 1960s and
came under the jurisdiction of the Swedish Food Act in
1971, the state-owned company responsible for snus
production at the time modernized the production tech-
niques and introduced several programs for quality
assurance and quality control. This later formed the
basis for a comprehensive quality standard for Swedish
snus named GothiaTek
®.
The current paper is a summary of the background
and rationale for these developments together with a
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Swedish snus, a product category that is central to cur-
rent discussions about the possibilities of harm reduc-
tion in the tobacco area. Although the GothiaTek
®
standard sometimes is referenced in the scientific litera-
ture, no authoritative publication describing it has pre-
viously been published.
Definition of Swedish snus
According to the trade organization European Smoke-
less Tobacco Council (ESTOC), “snus” is defined as a
ST product for oral use “traditionally produced and
used in Sweden ... the manufacturing process is a heat
treatment process” [7].. This definition distinguishes
snus from all other types of ST including some products
recently introduced on the North American market
which have distinctly different characteristics [8].
The 2009 WHO TobReg report underscored that “the
differences in risks associated with use of different smoke-
less tobacco products mean that it would be scientifically
inappropriate to consider smokeless tobacco as a single
product for the purposes of estimating risk or setting poli-
cies”. Hence, it is critical to use clear definitions of ST
products when discussing risk differentiation. In this
paper we refer to Swedish snus by the ESTOC definition
and not any wider, arbitrary definition.
History of snus
Swedish snus was invented during the early 1800s. It
was made of ground tobacco leaves, water, salt, and
potash [9]. Ease of use during manual work compared
to smoked tobacco and a low cost probably contributed
to its popular appeal. Traditionally the snus pinch was
placed between the gum and the anterior part of the
upper lip, that is, at a distance from the orifices of the
large salivary glands. This meant that there was no
excessive saliva mixed with the tobacco, which obviated
the need for spitting, a habit typically associated with
some other forms of ST usage.
Until the early 1940s snus was the predominant form
of tobacco used in Sweden (Figure 1). During the 1930s
cigarettes gained popularity, and eventually replaced
snus as the most commonly used tobacco product, an
epidemic similar to that in most western countries dur-
ing the 20
th century.
In the 1960s the Royal College of Physicians [10] and
the U.S. Surgeon General [11] published reports that
linked smoking to lung cancer. This contributed to
increased societal smoking control efforts and a shift in
tobacco habits that started during the late 1960s: a
decline of cigarette smoking and an increase in use of
snus (Figure 1).
Although snus has never been marketed as a smoking
cessation aid, many Scandinavian smokers have replaced
cigarettes with snus [6,12]. In population-based surveys,
snus is the most frequently reported cessation aid, and
use of snus is associated with higher rates of sustained
quitting than other methods, such as, nicotine replace-
ment therapy [5,6,13]. However, the role of snus for
smoking cessation remains controversial. Critics have
pointed out the observational character of the available
data, and the lack of controlled clinical trials.
Snus has always been the predominant form of smo-
keless tobacco in Sweden. Other types, such as, chewing
tobacco have always constituted less than one per cent
of the total sales of ST (Figure 1).
Since the formation in 1915 of the Swedish state-
owned tobacco monopoly (dismantled during the 1960s)
snus has been produced by essentially one company,
either the Tobacco Monopoly, or its successors: the
state-owned company (STA) which was transformed
during the 1990s into the current private company
Swedish Match. The first competitor appeared in 1992,
and today there are several manufacturers of snus in
Sweden. However, Swedish Match retains a market
share of c.85%.
Production methods
The early years
Documents in the archives of the Swedish Tobacco
Museum include recipes for snus production dating
back to the early 1800s. One of the oldest is the formula
for “The Making of Ljunglöf’s well-reputed Snus” [14]
which prescribes a mixture of Swedish and American
tobacco. The tobacco was ground into a powder which
was sifted in a rotating metal drum. One batch consisted
of 144 kg of leaf powder. A total of 133 liters of water
were used for moistening, plus 2.3 liters of table salt.
The powder, salt and water were mixed and put into
wooden cases to stand for six days in a warm oven.
After that 15 kg of potash was mixed in, and the snus
was cooled and became ready for use.
Documents in the Tobacco Museum archives reveal
that recipes and production techniques used by other
manufacturers at the time were similar to Ljunglöf’s. In
particular, they also used variations of the heat treat-
ment technique [9]. The temperatures used typically
ranged from 50 to 80 degrees Centigrade. Most manu-
facturers used flavorings, such as, salmiac, pepper, and
lemon or bergamot oil [I. Junhem, personal
communication].
During the 20
th century production of snus became
more centralized. In the late 1960s snus was only pro-
duced in one factory using almost the same recipes and
manual production techniques as during the 1800s,
although the temperature during the heat treatment had
been raised slightly to decrease problems related to
microbial contamination.
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With the growing popularity of snus in the late 1960s,
several quality problems were noted with the old, man-
ual production techniques. During storage ammonia was
sometimes formed in the finished products resulting in
an uncontrolled increase in pH. The exact chemical
mechanisms behind this phenomenon were largely
unknown. This prompted a research and development
program aimed at finding methods to deal with the
quality problems with the old techniques.
The most important outcome was the introduction of
a modernized manufacturing process at a newly built
factory in 1982. Another impetus for the quality devel-
opment was that snus came under the jurisdiction of
the Swedish Food Act in 1971. The rationale was that it
i sc o n s u m e di nt h em o u t h ,a n d ,t h e r e f o r e ,i sp a r t l y
ingested. Compliance with the Food Act implied stricter
hygienic requirements and restrictions as to the range of
allowed ingredients, additives, and containers, all of
which must be food-grade.
As a result of collaboration with the Swedish Food
Authority several initiatives for quality assurance and
quality control were successively introduced in the pro-
duction during the 1970s through the 1990s. This colla-
boration was in part a response to the scientific and
public debates about health effects of tobacco products
in general, and, more specifically, the role of potential
toxicants and agrochemical residues in smokeless
tobacco products - which paralleled a similar debate
concerning food stuffs. The routine monitoring of the
chemical properties of snus was greatly expanded; assays
of tobacco-specific nitrosamines (TSNAs) were intro-
duced in 1984, and an extensive, annual chemical testing
of all snus brands started in 1988.
These initiatives and programs subsequently formed
the basis for a voluntary, comprehensive quality stan-
dard named GothiaTek
®.I tw a sf i r s ta n n o u n c e do na
company web-site in 2000, although the components of
the standard had been phased into the routine produc-
tion since the early 1980s [15].
Figure 1 Tobacco sales in Sweden 1916-2008 according to product category. The data refer to estimates of delivered quantities to points
of sale with adjustment for recalls and returns. Available official records do not permit adjustments for tax-free or cross-border trading, nor for
illegal entries into or out of the country. RYO: “Roll-your-own” tobacco, ST: smokeless tobacco [37-39].
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Research during the 1970s revealed that the main cause
of the quality problems with snus was related to micro-
bial growth, either because of residual bacterial activity
after the heat treatment or bacterial contamination dur-
ing the old, manual production process. This open man-
ufacture was also sensitive to contamination with
moulds, particularly if pH was below c. 8.
Toxicologists at the Swedish Food Authority noted in
the mid 1970s that snus occasionally could contain high
levels of nitrite, probably due to growth of nitrate-redu-
cing bacteria. Research about health effects of nitrite
and its relation to the formation of potentially carcino-
genic nitrosamines had started already in the 1960s and
was widely publicized in the 1970s and 1980s.
Several measures were tested to reduce the microbial
activity in snus, to prevent the formation of nitrite, and
to improve the stability of the finished product, while at
the same time not compromising consumer acceptance.
Eventually, the optimal approach was found to be a
combination of a modified production technique based
on processing of the ground tobacco in closed process
blenders at much higher temperatures than previously,
pH stabilization with sodium carbonate, and use of
humectants to lower the water activity in the finished
product. Products with a high water activity tend to
support more microorganisms.
The new production methods resulted in a finished
product with virtually no microbial activity, and a much
improved, and consistent stability. Consumer testing
among individuals used to the “old” snus products also
indicated a high level of acceptance.
Modern production of snus
A blend of leaf tobaccos is ground and sieved to speci-
fied particle sizes. The ground tobacco is mixed with
water and sodium chloride in closed process blenders.
The mixture is then subjected to a computer-controlled
heat-treatment process, the purpose of which is to
improve the taste and to reduce microbial activity to
obtain a proper shelf life. The heating is achieved by
using hot water and by injecting steam into the blen-
ders. It involves temperatures up to 80-100 degrees cen-
tigrade during several hours. Finally the snus is cooled
and other ingredients such as flavors and humectants
are added before the finished product is fed to auto-
matic packers.
Retailers are encouraged to keep the snus refrigerated
in order to meet the criteria for the “best-before” label-
ing. However, there is no need for a completely uninter-
rupted cool chain as the low bacterial activity in the
product implies stability also at room temperature.
“Snus ageing”
It has always been known that snus has a limited shelf
life and in this regard suffers from similar problems as
most other food stuffs with a high water content. How-
ever, before the introduction of the modified production
techniques in 1982, the most prominent problems with
snus quality were related to microbial activity, formation
of nitrite (and, hence, probably TSNA formation), and an
uncontrolled increase in pH. Snus produced with the
modern techniques has a very low microbial activity and
is thus much more stable. Today, ageing implies reduced
water content, and a consequent loss of perceived pro-
duct freshness, decrease in pH (related to a combination
of oxidation of tobacco constituents and evaporation of
volatile amines, including ammonia) and a decrease in
nicotine content also due to oxidation. Figure 2 shows
the natural decline of pH over time at room temperature
in modern snus. Nitrosamines are not formed in the con-
tainer during storage, even if kept at room temperature
[16]. Snus ageing can be slowed by keeping the product
refrigerated below 8 degrees centigrade. Ageing is more
or less halted if the product is deep frozen.
Chemical composition of snus
The components of Swedish snus are a blend of air and/
or sun-cured tobacco, water, sodium chloride, sodium
carbonate, humectants, and flavoring agents.
The water content is around 45-60%. Sodium chloride
adds flavor and prevents microbial activity. Sodium car-
bonate helps to stabilize the pH. The target pH level in
the production of most traditional snus brands is about
8.5 with some batch to batch variation due to natural
variation of the raw tobacco. Before the 1970s the pH of
snus was typically higher, but with the introduction of
new production technique, the target pH level was
intentionally reduced as a result of research on “snus
lesions” in the gingival and buccal mucosa which were
found to be related to pH level [17]. Abrasions of the
Figure 2 Natural decline of pH in snus (pouch products)
manufactured according to the GothiaTek
® standard during
storage at 20 degrees centigrade (data based on internal
Swedish Match documentation).
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increase the absorption of potential toxicants. Tradition-
ally potassium carbonate was used instead of sodium
carbonate. The switch was made for technical reasons:
s o d i u mc a r b o n a t ei sm o r ew a t e rs o l u b l ea n du s i n ga
water solution facilitates the production.
Humectants, such as, propylene glycol and glycerol,
serve two purposes; to retain moisture, and lower the
water activity.
Snus is typically flavored using food approved flavors
to achieve the desired brand characteristics. In part, fla-
voring is used to compensate for the fact that fire-cured
tobacco is no longer used in snus (see section on “The
GothiaTek
® standard”).
Swedish snus does not contain added sugars. The low
sugar content (<2%) comes solely from the tobacco.
Constituents
There are several thousands of different constituents in
natural, raw tobacco [18]. The number is probably similar
to that found in other plants and in common food-stuffs.
Major classes include: primary plant metabolites such as
amino acids and proteins, carbohydrates, lignins, fatty
acids, and degradation products from chlorophyll. Raw
tobacco also contains secondary metabolites such as nico-
tine and related alkaloids, flavonoids, and polyphenols, as
well as isoprenoids and degraded isoprenoids. Contami-
nants taken up from the soil, agrochemicals, or air-borne
pollution include heavy metals, and radiochemicals.
About 40-50 compounds with possible health signifi-
cance may be found in smokeless tobacco products
including N-nitrosamines (particularly the tobacco-spe-
cific nitrosamines, TSNAs), volatile aldehydes, polyaro-
matic hydrocarbons (PAHs), heavy metals (e g
cadmium, arsenic, nickel, chromium, lead), and radioiso-
topes (e. g. Polonium-210).
Tobacco also contains substances that are potentially
antimutagenic and anticarcinogenic including ubiqui-
nione, alpa-tocopherol, flavonoids, isoprenoids, and cer-
tain fatty acids [19-22]. It has not been determined if
the concentrations of these compounds in Swedish snus
products are sufficient to provide protective effects.
The GothiaTek
® standard
The standard was based on the mentioned research and
development efforts dating back to the early 1970s. The
different components were phased into the production
during the 1980s and 1990s. However, it was not until
t h el a t e1 9 9 0 st h a tt h ee n t i r ep r o d u c t i o nw a sf u l l yc o n -
sistent with the standard [15].
The principal components of the standard are:
￿ Constituent standard
○ Maximum levels (MLs) for selected, undesired
constituents in the finished products (see Table 1)
○ Guidance Residue Levels (GRLs) for agrochem-
ical residues in finished products
￿ Manufacturing standard
○ A standard for selection of raw materials:
■ Leaf tobacco selection and an “early warn-
ing” chemical analysis program designed so
that the limits for undesired constituents in
finished products are met.
■ An ingredient policy consistent with the
Swedish Food Act for additives and flavorings.
○ Requirements for the manufacturing process.
■ Tobacco comminuted in a controlled pro-
cess satisfying the requirements for specific
particle size distributions.
■ Controlled heat treatment that reduces the
natural microbial flora of the tobacco to spe-
cified residual limits.
■ Manufacturing in a closed system to pre-
vent the product from being contaminated by
e.g. external microflora
■ Hygienic conditions complying with the
Swedish Food Act
￿ Consumer information:
○ Consumer package labeling including a best
before date, recommended storage conditions, and
a declaration of ingredients in accordance with
requirements for labeling of processed food stuffs
○ A public web-site with detailed information on
brand-specific product characteristics, and
updated summaries of research results on health
effects of snus.
Constituent standard
While TSNAs are specific to tobacco, the remaining
constituents covered by the standard are also found in
many food stuffs.
Table 1 Maximum Levels (MLs) for unwanted substances
in Swedish snus according to GothiaTek
® (dry weight),
and average observed levels in Swedish Match’s snus
products 2009 (data based on internal Swedish Match
documentation)
Substance GothiaTek
®
ML
Average level
2009
Nitrite 7.0 ppm 2.0 ppm
TSNAs (total) 10.0 ppm 1.6 ppm
N-Nitrosodimethylamine
(NDMA)
10.0 ppb 0.7 ppb
Benzo(a)pyrene (B(a)P) 20.0 ppb 1.1 ppb
Lead 2.0 ppm 0.3 ppm
Cadmium 1 ppm 0.6 ppm
Arsenic 0.5 ppm 0.1 ppm
Nickel 4.5 ppm 1.3 ppm
Chromium 3.0 ppm 0.8 ppm
ppm: parts per million (corresponding to μg/g).
ppb: parts per billion (corresponding to ng/g).
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standard reflects in part the quality problems that were
detected during the 1970s before the modified produc-
tion techniques for snus were introduced, for instance,
nitrite formation.
In a report from the U.S. Department of Health pub-
lished in 1986 it was suggested that the most important
carcinogenic substances found in ST products were
N-nitrosamines, polyaromatic hydrocarbons (PAHs), and
radioisotopes (particularly Polonium-210) [23]. MLs
were therefore defined for TSNAs and B(a)P as these
were considered to be the most important compounds
from a carcinogenic perspective in their respective class.
Limits for radioisotopes were not included in Gothia-
Tek
® as the effective radiation dose from Polonium
among habitual snus users was estimated to be compar-
able to that from the natural background radiation
sources or dental x-rays [24].
As snus is regulated under the Swedish Food Act, it
was considered reasonable to include lead, cadmium,
nickel, and arsenic as these compounds were known to
be present in many leafy vegetables (including tobacco),
as they were known to have potential health effects, and
as limits were defined in the Food Act for selected food
stuffs. However, the Act has never set limits for consti-
tuents in smokeless tobacco products, with the excep-
tion of lead for which the ML is 3 μg/g.
In selecting the constituents to be included in the
standard, consideration was also given to a list published
by Hoffman & Djordjevic in 1997 [25]. Their list is more
extensive than the U.S. Department of Health list from
1986 and includes some constituents that were not
included in GothiaTek
®, such as alpha/beta-angelica lac-
tone, coumarin, hydrazine, volatile aldehydes, and ethyl
carbamate (urethane). The main reasons for exclusion of
t h e s ea d d i t i o n a la n a l y t e sw e r et h a tt h e yw e r ef o u n dt o
be non-detectable or present only in trace amounts in
snus, that robust analytical methods were unavailable at
the time, or that technical developments of the produc-
tion were not expected to result in decreased levels of
the constituent.
T h eM L sd e f i n e db yG o t h i a T e k
® were pragmatic and
based on considerations of what could be consistently
achieved in large-scale production, comparisons with
levels observed in common food stuffs, comparisons
with estimated total daily exposure from food and
drinking water, and from the observations in Swedish
epidemiological studies of no increased risk of oral can-
cer associated with long-term use of Swedish snus with
a TSNA and B(a)P content substantially higher than the
defined limits [26,27].
Aside from GothiaTek
® no voluntary standard for ST
products has been introduced that include MLs for
potential toxicants. Nevertheless, quality development by
several manufacturers has resulted in decreased levels of
nitrosamines in many traditional brands of American
moist snuff and other ST products on the North Ameri-
can market. However, as a result of a persistent use of
fire-cured tobacco, levels of B(a)P have typically
remained relatively high except in some novel products
marketed as “snus” [28].
The Swedish Match agrochemical policy
In short, this policy requires that the contribution of
agrochemical residues (pesticides, fungicides, and herbi-
cides) from 25 g of snus shall not exceed 2.5% of the
defined acceptable daily intake (ADI) according to Eur-
opean Union regulations. Acceptable levels may be set
lower if implied by e.g. a legislated ML in any country
for the agrochemical in question. Lower levels are also
s e ti fi m p l i e db yl e v e l ss e tb y“The Cooperation Centre
for Scientific Research Relative to Tobacco”
(CORESTA).
Raw tobacco selection
Traditionally snus was made from a selection of tobacco
varieties typically including a large proportion of fire-
cured tobacco. This resulted in relatively high levels of
PAH:s in the finished products. During the 1990s use of
fire-cured tobacco was phased out. Consequently, over a
period of a few years, the level of B(a)P in finished
snus products decreased from c. 20-25 ng/g to less than
2-3 ng/g based on dry weight (Figure 3). Fire-cured tobacco
adds a distinct flavor, but the traditional flavor characteris-
tics were preserved using food-approved flavorings.
In the early 1980s it was discovered that the main
source of TSNAs in snus was certain varieties of leaf
Figure 3 Average levels of NNN (N’-nitrosonornicotine), NNK
(4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone), total TSNAs,
and B(a)P (dry weight) in Swedish Match’s snus products 1984-
2009 (data based on internal Swedish Match documentation).
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curing and typically increase if the tobacco is fermented.
The levels may also increase in finished products as a
result of nitrate-reducing microbial activity leading to
formation of nitrite. The nitrate content of raw tobacco
is dependent on local growing conditions and may
increase, for instance, if the plants are excessively
fertilized.
This awareness started research to clarify the mechan-
isms of TSNA formation during air-curing of tobacco,
both within the company and in cooperation with uni-
versity scientists with expertise in agronomy. The find-
ings were evaluated in experiments involving seed
selection, modified cultivation and curing methods
[30-32]. It was also secured that the heat treatment did
not lead to increased levels of TSNAs.
Curing of tobacco is essential to achieve desired flavor
characteristics. Today, Swedish snus manufactured
according to GothiaTek
® is exclusively made from
selected, low-nitrosamine raw tobacco (N. tabacum) that
has been air or sun-cured. This means that curing is
achieved without artificial sources of heat and humidity.
The curing involves complex physical and chemical
changes that occur as the tobacco leaves loose moisture.
Because these changes do not occur under a prescribed
set of temperature and humidities, and because the che-
mical composition of the leaves are dependent on the
climate and other growing conditions, the end product
may differ considerably from one location to another
and from year to year. This helps to explain why the
composition of the raw tobacco used in modern snus
production varies from year to year.
To achieve the constituent limits set by GothiaTek
®,a
program was implemented based on collaboration with
local growers with regard to use of seeds, agrochemicals
and production techniques. An “early warning” system
was also introduced including multiple sampling and
chemical analyses of the tobacco, and specifications for
approval before shipment. As a result, the TSNA con-
tent in finished snus products has decreased continu-
ously and substantially since routine analyses were
initiated in 1984. When the testing started the observed
average levels were about 15-20 μg/g based on dry
w e i g h t ,c o m p a r e dt oc .1 - 2μg/g during recent years
(Figure 3).
Chemical properties versus epidemiology
Numerous analytical epidemiological studies have been
published that have looked at health effects of Swedish
snus [33]. In practice, such studies invariably concern
exposure to the type of snus products that were on the
market many years ago. For instance, in one population-
based case-control study of head-neck cancer conducted
in the early 1990s, the average duration of use among
those who were ever snus users was c. 20 years [26].
This means that the typical user started using snus in
the early 1970s. A recent publication based on the
Swedish Construction Worker Cohort [34] presented
detailed information on duration of snus usage among
more than 40,000 snus consumers; at inclusion in the
study (1971-75 and 1978-1992), 64% reported use dur-
ing 1- 9 years, 28% during 10-24 years, and 8% reported
use during more than 25 years. This implies that almost
two thirds of the snus users in this cohort started their
snus habit during the 1970s or later.
These data make it evident that some of the epidemio-
logical documentation about the health effects of Swed-
ish snus relate to products manufactured before the era
of the GothiaTek
® standard. Consequently, the snus
users in these studies were exposed to products with
substantially higher levels of e.g. TSNAs and B(a)P than
is the case today. Theoretically, it is possible that the
lowered levels of toxicants in “modern” snus imply that
the health effect profile of snus has improved but this
hypothesis awaits epidemiological confirmation.
Conclusions
The first impetus for the work that later formed the
basis for the GothiaTek
® standard was problems related
to microbial activity and poor product quality. However,
as a result of snus being regulated under the Swedish
Food Act since 1971, and the emerging scientific debate
about the content of potential toxicants in tobacco pro-
ducts, there was also an early recognition of the need to
decrease the levels of a range of undesired substances in
snus. Collaboration between toxicologists at the Swedish
Food Authority and the company responsible for all
snus production at the time was pivotal for the develop-
ment of the standard and was facilitated by the fact that
both institutions belonged to the Swedish state.
GothiaTek
® has been accepted by the members of the
trade organization European Smokeless Tobacco Coun-
cil (ESTOC). It has thus become a voluntary standard
for all smokeless tobacco products in Europe. The stan-
dard formed the basis for ESTOC’s recent proposal to
the European Union health authority (the directorate
general for health and consumer protection, DG
SANCO) for a science-based regulation of smokeless
tobacco products within the EU.
The selection of constituents regulated in GothiaTek
®
and the corresponding MLs were pragmatic; the stan-
dard included the toxicants that, at the time, were con-
sidered to be the quantitatively most important for the
toxicity of ST products, for instance, TSNAs and B(a)P,
b u te x c l u d e ds o m eo na c c o u n to fu n a v a i l a b i l i t yo f
robust analytical methods (e.g. volatile aldehydes). The
most important criterion for the selection of toxicants
was the toxicity evidence, but the MLs were pragmatic
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nically be achieved in large-scale, routine production,
although it was noted that typically this meant levels
and/or exposures that were comparable or even lower
than from many common food stuffs. The decision not
to include radioisotopes, such as Polonium-210, in the
standard was based on considerations that could be
described as “hazard prioritization"; absorbed radiation
doses among habitual snus users were estimated to be
comparable to those from the natural background
radiation.
The GothiaTek
® standard reflects the toxicological
science and production techniques of the 1990s; the tox-
icant levels achieved today in routine production are
lower, or much lower, than the MLs defined by Gothia-
Tek
® (Table 1). Techniques for chemical analysis have
improved. Also, an improved scientific base now exists
for formal toxicological risk assessments of different
tobacco products. These circumstances suggest that it is
now appropriate to revisit the MLs according to Gothia-
Tek
® as well as the selection of regulated constituents.
The standard should also be updated based on a mod-
ern risk assessment approach.
The WHO Framework Convention for Tobacco Con-
trol (FCTC) recognizes the need for tobacco product
regulation [35]. As a result, the WHO TobReg has pub-
lished several reports to provide a scientific foundation
for such regulation. A recent paper summarized a pro-
posal developed by a joint IARC and WHO working
group for performance standards for cigarettes and a
strategy to use them to mandate a reduction in the toxi-
cant yields for cigarette smoke [36]. There are obviously
major differences between regulating cigarettes com-
pared to ST products. However, some basic principles
suggested by the report might be applicable also to ST
products: initiation of policy change beginning with
annual reporting of selected toxicant levels from manu-
facturers to regulatory authorities, followed by the pro-
mulgation of MLs based on what may be achievable
with new technology or product designs, selection of
toxicants from comprehensive lists including those com-
pounds thought to play a major role for product toxi-
city, prioritization within those lists based on available
animal and human toxicity data, toxic potency, and con-
siderations related to what technically may be achieved.
The report also acknowledges the potential problem of
unintended changes in non-regulated substances.
An issue specific to ST products is the extraction rate
of different constituents. In contrast to food stuffs ST is
not ingested, only a proportion of the content of poten-
tial toxicants is extracted from the product, which needs
to be taken into account in a risk management analysis.
An important aspect when applying regulatory science
to tobacco products is the availability of validated
analytical techniques. In support of work to further
develop standards for smokeless tobacco, proficiency
testing of selected analytes was done at several labora-
tories in Europe coordinated by a working group under
the auspices of the ESTOC Scientific Advisory Commit-
tee. This work is now continued and expanded by a
newly formed CORESTA Subcommittee for ST
products.
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